Brooklyn John R, Sigmon Stacey C
Department of Psychiatry (JRB, SCS); Department of Psychology (SCS), University of Vermont, Burlington, VT.
J Addict Med. 2017 Jul/Aug;11(4):286-292. doi: 10.1097/ADM.0000000000000310.
Opioid use disorders (OUDs) are reaching epidemic proportions in the United States, and many geographic areas struggle with a persistent shortage in availability of opioid agonist treatment. Over the past 5 years, Vermont addiction medicine physicians and public health leaders have responded to these challenges by developing an integrated hub-and-spoke opioid treatment network.
In the present report, we review the development, implementation, and impact of this novel hub-and-spoke model for expanding OUD treatment in Vermont.
Vermont's hub-and-spoke system has been implemented state-wide and well-received by providers and patients alike. Adoption of this model has been associated with substantial increases in the state's OUD treatment capacity, with Vermont now having the highest capacity for treating OUD in the United States with 10.56 people in treatment per 1000. There has been a 64% increase in physicians waivered to prescribe buprenorphine, a 50% increase in patients served per waivered physician, and a robust bidirectional transfer of patients between hubs and spokes based upon clinical need. Challenges to system implementation and important future directions are discussed.
Development and implementation of a hub-and-spoke system of care has contributed substantially to improvements in opioid agonist treatment capacity in Vermont. This system may serve as a model for other states grappling with the current opioid use epidemic.
阿片类药物使用障碍(OUDs)在美国正呈流行态势,许多地区都面临阿片类激动剂治疗可及性持续短缺的问题。在过去5年里,佛蒙特州的成瘾医学医生和公共卫生领导人通过建立一个综合性的中心辐射型阿片类药物治疗网络来应对这些挑战。
在本报告中,我们回顾了这种新型中心辐射型模式在佛蒙特州扩大阿片类药物使用障碍治疗方面的发展、实施情况及影响。
佛蒙特州的中心辐射型系统已在全州实施,并受到了医疗服务提供者和患者的一致好评。采用这种模式使该州的阿片类药物使用障碍治疗能力大幅提高,佛蒙特州目前是美国治疗阿片类药物使用障碍能力最高的州,每1000人中有10.56人接受治疗。获得丁丙诺啡处方豁免的医生增加了64%,每位获得豁免的医生服务的患者增加了50%,并且患者根据临床需求在中心和辐射点之间进行了强劲的双向转诊。讨论了系统实施面临的挑战和重要的未来发展方向。
中心辐射型护理系统的开发和实施极大地促进了佛蒙特州阿片类激动剂治疗能力的提高。该系统可为其他正在应对当前阿片类药物使用流行问题的州提供一个模式。